🟢 Azitra is trading 5% up in pre-market

Azitra is trading 5.36% higher at $1.18 in pre-market; no confirmed company-specific announcement explains the October 28 move.

• The October 26 release reported positive ex vivo ATR-COSF results.
• Azitra said initial human-study data are expected by year-end; the earlier release does not establish the cause of this move.